Duke Clinical Research Institute
2400 Pratt Street
About Duke Clinical Research InstituteFocus
For over three decades, the Duke Clinical Research Institute has been helping the pharmaceutical, medical device, and biotech industries develop new therapeutic options. We offer a unique combination of clinical expertise, academic leadership, operational capabilities, and business acumen that translates into targeted and sound research results. With thought-leaders capable of staying at the cutting edge of science and the business of the industry, our efforts consistently help sponsors be first to market and first to peak sales. The DCRI achieves this by integrating scientific thought-leadership with full-service operational capabilities in Phase I-IV multi-center clinical trials and outcomes research. Over 800 employees collaborate across all disciplines to create successful projects.
Breadth and Depth
The DCRI enlists more than 5000 investigators in over 70 countries to carry out scientific investigations, reflecting the DCRI's tremendous experience and knowledge of the cultural differences in clinical practice and clinical research capabilities. More than a decade of globe-spanning trials experience means smooth oversight across time and geography. Though best known for our pioneering research in cardiology, DCRI research spans the scientific gamut, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics and proteomics. In recent years, our expertise in infectious disease, oncology, and central nervous system research has grown tremendously. Our knowledge and experience continue to expand and now encompass the following:
* Anesthesiology * Otolaryngology * Cardiology * Pediatrics * Cardiothoracic surgery * Pulmonary medicine * Endocrinology * Primary care * Gastroenterology * Psychiatry * Geriatrics * Reproductive * Hematology medicine * Infectious disease * Rheumatology * Nephrology * Transplant medicine * Oncology * Women's health * Ophthalmology
Last Updated: 06-09-05
33 articles with Duke Clinical Research Institute
HumanFirst and Duke Clinical Research Institute Collaborate to Improve Scientific Rigor for Digital Measures
HumanFirst and the Duke Clinical Research Institute announced the creation of a new Digital Measures Evaluation Center for assessing sensors and other digital measures used in clinical research.
9 Meters Biopharma, Inc. Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters' Program in Short Bowel Syndrome
9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today that the Company will enter into a collaboration with the Duke Clinical Research Institute (DCRI) to support the clinical development of 9 Meters candidate NM-002, a proprietary long-acting GLP-1 agonist, currently in Phase 2 development for short bowel syndrome (SBS).
One in three people working in health care report their financial security has been impacted by the COVID-19 pandemic, according to a new poll conducted by the HERO Registry, a nationwide community of healthcare workers created to understand the impact of the COVID-19 pandemic on the front line.
TFS recently entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization's study portfolio. The partnership supports TFS's growth strategy and aligns its clinical development services with an organization renowned for bringing
North Carolina researchers call for a diverse group of essential workers in health care to join HeroesResearch.org to share experiences and evaluate prevention strategies
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
EMPACT-MI is the first trial in the SGLT2 inhibitor class to investigate the prevention of heart failure after acute myocardial infarction in adults with and without diabetes
HeroesResearch.org clinical research registry launches to answer crucial questions about the impact of novel coronavirus on healthcare workers' lives
11/18/2019It was a busy week for clinical trial announcements. Here’s a look.
Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease
The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S.
A new clinical trial finds that many patients who were treated for iron deficiency anemia with ferric carboxymaltose showed persistent hypophosphatemia five weeks after receiving the treatment.
Reflexion Health and Duke Clinical Research Institute Announce Results of the First Randomized Controlled Trial Demonstrating Virtual Physical Therapy Outperforms Traditional Approach
Reflexion Health's FDA-cleared, virtual outpatient physical therapy platform reduces costs for patients following total knee replacement surgery
Datavant Selects the Duke Clinical Research Institute as Founding Academic Partner to Accelerate Innovation in Data-Driven Clinical Research
Datavant announced today that it has selected the Duke Clinical Research Institute, the world's largest academic clinical research organization, as an analytical partner to accelerate data-driven approaches in drug development.
Duke Clinical Research Institute Release: New Collaborative Effort Aims To Improve Adult Vaccination Rates Within Primary Care Setting
Boehringer Ingelheim And Duke Clinical Research Institute Expand Collaboration To Create Largest Patient Registry For Idiopathic Pulmonary Fibrosis (IPF)
Boehringer Ingelheim Corporation And Duke Clinical Research Institute Form Collaborative Partnership To Study The Natural History Of Idiopathic Pulmonary Fibrosis (IPF)
Oxygen Biotherapeutics, Inc. Selects Duke Clinical Research Institute To Conduct Phase 3 Trial Of Levosimendan
Copernicus Group IRB Collaborating With Drug Information Association and Duke Clinical Research Institute Unit on Global Clinical Trial Conference
Study Shows Balloon Pump Use Prior to Angioplasty Does Not Reduce Heart Muscle Damage, Duke Clinical Research Institute Study
New Agent Prevents Stroke in Patients With Atrial Fibrillation, Duke Clinical Research Institute Study Suggests